Resource: FDA COVID-19 Updates
Source: U.S. Food and Drug Administration
Synopsis:
-
The FDA updated guidance on the use of COVID-19 convalescent plasma. This extends the treatment. Through the end of February 2021 patients may receive treatment with convalescent plasma and includes a new recommendation that convalescent plasma should not be collected from individuals who have received the COVID-19 vaccine.
-
The FDA published a new web page titled “A closer look at COVID-19 diagnostic testing.” This is a source for all healthcare providers and public health officials to examine COVID-19 tests, and includes information on both diagnostic and antibody testing for COVID-19.
-
To date there are now 223 molecular tests, 58 antibody tests, and 7 antigen tests.
Comment: Obviously the FDA believes in the use of convalescent plasma is to treat patients with COVID-19 in a hospital situation. They are continuing the allowance of this treatment through February 2021. The article written on “a closer look at COVID-19 diagnostic testing” is in plain language and is a good source for practitioners like us who make clinical decisions on testing for our patients and purchasing such equipment. The private sector continues to deliver unprecedented numbers of tests which the FDA has offered emergency use authorization.
